These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 29131328)

  • 1. Headache Education Active-Waiting Directive: A Program to Enhance Well-Being During Long Referral Wait Times.
    Lagman-Bartolome AM; Lawler V; Lay C
    Headache; 2018 Jan; 58(1):109-117. PubMed ID: 29131328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Headache management program improves outcome for chronic headache.
    Harpole LH; Samsa GP; Jurgelski AE; Shipley JL; Bernstein A; Matchar DB
    Headache; 2003; 43(7):715-24. PubMed ID: 12890125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up.
    Grazzi L; Andrasik F; D'Amico D; Usai S; Kass S; Bussone G
    Headache; 2004; 44(7):678-83. PubMed ID: 15209690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Employee and Employer Benefits From a Migraine Management Program: Disease Outcomes and Cost Analysis.
    Schaetz L; Rimner T; Pathak P; Fang J; Chandrasekhar D; Mueller J; Sandor PS; Gantenbein AR
    Headache; 2020 Oct; 60(9):1947-1960. PubMed ID: 32799346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient Cohort.
    Schwedt TJ; Digre K; Tepper SJ; Spare NM; Ailani J; Birlea M; Burish M; Mechtler L; Gottschalk C; Quinn AM; McGillicuddy L; Bance L; Dumkrieger G; Chong CD; Dodick DW
    Headache; 2020 Feb; 60(2):337-347. PubMed ID: 31755111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A; Leonardi M; Bussone G; D'Amico D
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of intensive patient education on clinical outcome in a clinic-based migraine population.
    Rothrock JF; Parada VA; Sims C; Key K; Walters NS; Zweifler RM
    Headache; 2006 May; 46(5):726-31. PubMed ID: 16643574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication-overuse headache detoxification reduces headache disability - the Akershus study of chronic headache.
    Kristoffersen ES; Grande RB; Aaseth K; Russell MB; Lundqvist C
    Eur J Neurol; 2018 Sep; 25(9):1140-1147. PubMed ID: 29746011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire.
    Ertaş M; Siva A; Dalkara T; Uzuner N; Dora B; Inan L; Idiman F; Sarica Y; Selçuki D; Sirin H; Oğuzhanoğlu A; Irkeç C; Ozmenoğlu M; Ozbenli T; Oztürk M; Saip S; Neyal M; Zarifoğlu M;
    Headache; 2004 Sep; 44(8):786-93. PubMed ID: 15330825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological Factors Associated With Chronic Migraine and Severe Migraine-Related Disability: An Observational Study in a Tertiary Headache Center.
    Seng EK; Buse DC; Klepper JE; J Mayson S; Grinberg AS; Grosberg BM; Pavlovic JM; Robbins MS; Vollbracht SE; Lipton RB
    Headache; 2017 Apr; 57(4):593-604. PubMed ID: 28139000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine.
    Bigal ME; Rapoport AM; Lipton RB; Tepper SJ; Sheftell FD
    Headache; 2003 Apr; 43(4):336-42. PubMed ID: 12656704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire.
    Iigaya M; Sakai F; Kolodner KB; Lipton RB; Stewart WF
    Headache; 2003 Apr; 43(4):343-52. PubMed ID: 12656705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Need for care and perceptions of MIDAS among headache sufferers study.
    Stewart W; Lipton R
    CNS Drugs; 2002; 16 Suppl 1():5-11. PubMed ID: 12196034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability, Feasibility, and Cost of Telemedicine for Nonacute Headaches: A Randomized Study Comparing Video and Traditional Consultations.
    Müller KI; Alstadhaug KB; Bekkelund SI
    J Med Internet Res; 2016 May; 18(5):e140. PubMed ID: 27241876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of an intensive multidisciplinary headache treatment program.
    Gunreben-Stempfle B; Griessinger N; Lang E; Muehlhans B; Sittl R; Ulrich K
    Headache; 2009 Jul; 49(7):990-1000. PubMed ID: 19473281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migraine disability assessment (MIDAS) score: relation to headache frequency, pain intensity, and headache symptoms.
    Stewart WF; Lipton RB; Kolodner K
    Headache; 2003 Mar; 43(3):258-65. PubMed ID: 12603645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing migraine self-efficacy and reducing disability through a self-management program.
    Short AL
    J Am Assoc Nurse Pract; 2019 Nov; 33(1):20-28. PubMed ID: 31738274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the utility of in-clinic "rescue" therapy for acute migraine.
    Morey V; Rothrock JF
    Headache; 2008 Jun; 48(6):939-43. PubMed ID: 18549372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migraine education improves quality of life in a primary care setting.
    Smith TR; Nicholson RA; Banks JW
    Headache; 2010 Apr; 50(4):600-12. PubMed ID: 20148982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.